AMOXICILLIN AND CLAVULANATE POTASSIUM (amoxicillin and clavulanate potassium) by Aurobindo Pharma is 12. Approved for acute otitis media due to s, equal to 40 kg with recurrent, persistent acute otitis media due to s and 9 more indications. First approved in 2011.
Drug data last refreshed Yesterday
12.1 Mechanism of Action Amoxicillin and clavulanate potassium for oral suspension is an antibacterial drug [see ]. 12.3 Pharmacokinetics The pharmacokinetics of amoxicillin and clavulanate were determined in a study of 19 pediatric patients, 8 months to 11 years, given amoxicillin and clavulanate…
Worked on AMOXICILLIN AND CLAVULANATE POTASSIUM at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.